TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16534704

Group type: EXPERIMENTAL
Intervention: Uncemented Cone stem
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cemented Bimetric stem
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cone stems (follow-up study)
Number of subjects: 45
Study: 12495964

Group type: EXPERIMENTAL
Intervention: Cough frequency measured using an ambulatory cough meter
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: C2 (concentration of capsaicin causing two coughs)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: C5 (concentration of capsaicin causing five or more coughs)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Subjective cough scores (parent and child recorded)
Number of subjects: 40
Study: 11731752

Group type: EXPERIMENTAL
Intervention: Constant ventilation (group AA) during clamping
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Modified ventilation to preserve normocapnia (group AB) during clamping
Number of subjects: 25

Group type: COMPARATOR
Intervention: Constant ventilation (group OD) in occlusive patients
Number of subjects: 25
Study: 9415794

Group type: EXPERIMENTAL
Intervention: Brief clinician advice (30 seconds), a 15‐minute motivational session by counselors, and printed materials
Number of subjects: 516
Study: 8352668

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 30
Study: 3675128

Group type: EXPERIMENTAL
Intervention: Incremental information on how to do the Wisconsin Card Sorting Test, including explicit card-by-card instruction.
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (no incremental information provided).
Number of subjects: 3
Study: 29791681

Group type: EXPERIMENTAL
Intervention: Educational dance program for seven months
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (no educational dance)
Number of subjects: 85
Study: 26704742

Group type: EXPERIMENTAL
Intervention: Educational intervention before the second scenario
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (performed both scenarios before receiving the intervention)
Number of subjects: 33
Study: 24189463

Group type: EXPERIMENTAL
Intervention: Telmisartan 80mg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (other anti-hypertensive drugs)
Number of subjects: 50
Study: 23246868

Group type: EXPERIMENTAL
Intervention: Partly absorbable polypropylene-polyglactin mesh (Vypro II)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Lightweight polypropylene mesh (Premilene Mesh LP)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Conventional densely woven polypropylene mesh (Premilene)
Number of subjects: 312
Study: 21941778

Group type: EXPERIMENTAL
Intervention: HP
Number of subjects: 91

Group type: COMPARATOR
Intervention: HP-CVVH
Number of subjects: 91
Study: 17614245

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 677

Group type: COMPARATOR
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 677
Study: 17070177

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 496

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 496
Study: 12587969

Group type: EXPERIMENTAL
Intervention: Exercise training and education (Exercise group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Education alone (Control group)
Number of subjects: 66
Study: 11113218

Group type: EXPERIMENTAL
Intervention: rt-PA treatment within 0 to 90 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rt-PA treatment within 91 to 180 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (treated after 90 minutes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rt-PA treatment
Number of subjects: 0
Study: 9419073

Group type: EXPERIMENTAL
Intervention: Objects approaching from the right
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Objects approaching at different velocities and directions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal coordination between transport and grasp components
Number of subjects: 0
Study: 8402803

Group type: EXPERIMENTAL
Intervention: Biotene toothpaste (LPO system)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control toothpaste (Vademecum, no LPO system)
Number of subjects: 26
Study: 3324838

Group type: EXPERIMENTAL
Intervention: Intramuscular premedication with 0.12 mg.kg‐1 midazolam and 0.5 mg atropine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Atropine only (control group)
Number of subjects: 24
Study: 28903582

Group type: EXPERIMENTAL
Intervention: Methylprednisolone treatment group
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (no glucocorticoid treatment)
Number of subjects: 219
Study: 27863807

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol plus methotrexate
Number of subjects: 915

Group type: COMPARATOR
Intervention: Adalimumab plus methotrexate
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Switching to certolizumab pegol after non-response to adalimumab
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Switching to adalimumab after non-response to certolizumab pegol
Number of subjects: 915
Study: 25009196

Group type: EXPERIMENTAL
Intervention: Propofol-paravertebral block (PPA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sevoflurane-opioid (GA)
Number of subjects: 10
Study: 22561417

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise group
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Moderate- to high-intensity exercise group
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (routine physical therapy)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Exercise groups (combined low and moderate-to-high intensity)
Number of subjects: 174
Study: 16062003

Group type: EXPERIMENTAL
Intervention: Evidence-based prevention measures for falls and fractures
Number of subjects: 0
Study: 12468136

Group type: EXPERIMENTAL
Intervention: 25 mg DEX tablet
Number of subjects: 298

Group type: COMPARATOR
Intervention: Intracervical injection of 5 ml mepivacaine 2%
Number of subjects: 298
Study: 9659630

Group type: COMPARATOR
Intervention: Standard care (Medicare mammography benefit flier)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Education (flier and community education program)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Access (flier, mammography appointments, and transportation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined (all interventions)
Number of subjects: 40
Study: 8601046

Group type: EXPERIMENTAL
Intervention: Centrifugal blood pump (group II)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Roller pump plus aprotinin (group III)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Roller pump (group I)
Number of subjects: 120
Study: 2516361

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate nasal spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (saline) nasal spray
Number of subjects: 0
Study: 361144

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen
Number of subjects: 320

Group type: COMPARATOR
Intervention: Radiotherapy alone (Control)
Number of subjects: 320
Study: 31679747

Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention with weekly step goals
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 28870846

Group type: EXPERIMENTAL
Intervention: Price increase of 20% on 'red' beverages (nondiet soft drinks, energy drinks)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Price increase of 20% on 'amber' beverages (diet soft drinks, small pure fruit juices)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: No price change on 'green' beverages (water)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 352
Study: 27561175

Group type: EXPERIMENTAL
Intervention: Intranasal PH94B
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 24405979

Group type: COMPARATOR
Intervention: Low dose aspirin (75 mg daily)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination of low dose aspirin (75 mg daily) and low-molecular-weight heparin
Number of subjects: 150
Study: 22584174

Group type: EXPERIMENTAL
Intervention: Pinnacle3 treatment planning system using CCCS algorithm
Number of subjects: 11
Study: 20142239

Group type: EXPERIMENTAL
Intervention: Cytology screening with a cutoff of low-grade squamous intraepithelial lesion or worse
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: Cytology screening with original Pap I result
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: Screening laboratory rereading for detecting low-grade lesions or worse as atypical
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: CIN3+ diagnoses in the screened population
Number of subjects: 1336
Study: 18206529

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 16205134

Group type: EXPERIMENTAL
Intervention: DuraPrep solution plus Ioban 2 drapes
Number of subjects: 176

Group type: COMPARATOR
Intervention: povidone iodine scrub and paint plus Ioban 2 drapes
Number of subjects: 176
Study: 12019686

Group type: EXPERIMENTAL
Intervention: Back belts with use instruction
Number of subjects: 12772

Group type: COMPARATOR
Intervention: Lifting advice only
Number of subjects: 12772

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12772
Study: 10424635

Group type: EXPERIMENTAL
Intervention: Hand-held computer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paper and pencil form
Number of subjects: 0
Study: 8636525

Group type: EXPERIMENTAL
Intervention: New double-lumen catheter
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional suctioning
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional endotracheal lavage
Number of subjects: 40
Study: 2101781

Group type: EXPERIMENTAL
Intervention: Oral captopril 15 min before thrombolysis (37 patients)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Thrombolysis followed by oral captopril on day 3-4 (35 patients)
Number of subjects: 72
Study: 108748

Group type: EXPERIMENTAL
Intervention: (-) trans-delta9-tetrahydrocannabinol (THC) (320 microgram/kg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ethanol (0.54 g/kg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combination of THC and ethanol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 30421545

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study: 28449709

Group type: EXPERIMENTAL
Intervention: CME by Case Method
Number of subjects: 460

Group type: COMPARATOR
Intervention: Traditional lectures
Number of subjects: 460

Group type: COMPARATOR
Intervention: No CME (reference group)
Number of subjects: 460
Study: 25426542

Group type: EXPERIMENTAL
Intervention: Steep Ramp Test (SRT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Cardiopulmonary Exercise Test (CPET)
Number of subjects: 61
Study: 22884411

Group type: EXPERIMENTAL
Intervention: Structured procedure for setting health (care) priorities
Number of subjects: 317

Group type: COMPARATOR
Intervention: Standard care by control GPs
Number of subjects: 317
Study: 21434338

Group type: EXPERIMENTAL
Intervention: Qutan Huayu Jiedu (QHJ) herbs
Number of subjects: 83

Group type: COMPARATOR
Intervention: Qutan Huayu (QH) herbs (control)
Number of subjects: 83
Study: 19877106

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study: 17993437

Group type: EXPERIMENTAL
Intervention: Intramedullary pinning
Number of subjects: 36

Group type: COMPARATOR
Intervention: Transverse pinning
Number of subjects: 36
Study: 16304443

Group type: EXPERIMENTAL
Intervention: Sealant applied and reapplied up to 36 months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fluoride varnish applied and reapplied up to 42 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sealant group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fluoride varnish group
Number of subjects: 120
Study: 11890484

Group type: EXPERIMENTAL
Intervention: Two-stage intervention (screening and nursing assessment)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 388
Study: 9691229

Group type: EXPERIMENTAL
Intervention: Pyrazinoylguanidine (PZG), 400 mg three times a day for 3 weeks
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pyrazinoylguanidine (PZG)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 7918062

Group type: EXPERIMENTAL
Intervention: rGM-CSF
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 3395403

Group type: EXPERIMENTAL
Intervention: Vadocaine hydrochloride 10 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vadocaine hydrochloride 30 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Codeine phosphate 50 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29877169

Group type: EXPERIMENTAL
Intervention: Zinc-fortified water (ZFW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (FW)
Number of subjects: 0
Study: 28196256

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to increased WHR adjusted for BMI
Number of subjects: 111986
Study: 26232170

Group type: EXPERIMENTAL
Intervention: VR-CAP (rituximab, cyclophosphamide, doxorubicin, prednisone with bortezomib)
Number of subjects: 164

Group type: COMPARATOR
Intervention: R-CHOP (rituximab, cyclophosphamide, doxorubicin, prednisone with vincristine)
Number of subjects: 164
Study: 24029854

Group type: EXPERIMENTAL
Intervention: Bonfils Intubation Fiberscope
Number of subjects: 60

Group type: COMPARATOR
Intervention: McCoy laryngoscope
Number of subjects: 60
Study: 21159786

Group type: EXPERIMENTAL
Intervention: Magnesium citrate (500 mg elemental Mg/d)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 18763315

Group type: EXPERIMENTAL
Intervention: Combined scoring system (CSS) of zygote and embryo morphology
Number of subjects: 117

Group type: COMPARATOR
Intervention: Cumulative embryo score (CES)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Combined scoring system (CSS) for embryos scoring >=70
Number of subjects: 117

Group type: COMPARATOR
Intervention: Cumulative embryo score (CES) for embryos scoring >=20
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Combined scoring system (CSS) for embryos scoring <70
Number of subjects: 117
Study: 17117565

Group type: EXPERIMENTAL
Intervention: Combined regime of auricular-plaster and body acupuncture
Number of subjects: 92

Group type: COMPARATOR
Intervention: Body acupuncture (control)
Number of subjects: 92
Study: 12594582

Group type: EXPERIMENTAL
Intervention: Appropriate antibiotic therapy
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Inappropriate antibiotic therapy
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Microbiologically confirmed cases
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: ASA grade 3 or more
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Age 64 years or more
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Time to onset of pneumonia more than 3 days
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Mottling
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Hypotension
Number of subjects: 556
Study: 10930898

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg t.d.s.
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg b.d. (after 2 weeks of placebo or cisapride 10 mg t.d.s.)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg t.d.s. and 20 mg b.d. (in patients with abnormal baseline electrogastrograms)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (for the first 2 weeks)
Number of subjects: 38
Study: 8800872

Group type: EXPERIMENTAL
Intervention: Sodium ironedetate (Sytron) administered rectally at a concentration of 7.6 mg ml‐1
Number of subjects: 0
Study: 1353804

Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m2 plus 750 mg/m2 cyclophosphamide (high dose)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Cisplatin 50 mg/m2 plus 750 mg/m2 cyclophosphamide (low dose)
Number of subjects: 165
Study: 6615704

Group type: EXPERIMENTAL
Intervention: Fast inspiratory flow rate
Number of subjects: 43

Group type: COMPARATOR
Intervention: Lung volume at the time of aerosol release
Number of subjects: 43

Group type: COMPARATOR
Intervention: Time interval between the 2 puffs
Number of subjects: 43
Study: 31860959

Group type: EXPERIMENTAL
Intervention: Plasma levels of miR-200c-3p
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Plasma levels of miR-100-5p
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Plasma levels of miR-1826
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: miR-100-5p and DNMT3A mRNA levels
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: miR-100-5p and ZEB1 mRNA levels
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: miR-200c-3p and MMP13 mRNA levels
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: miR-1826 and CTNNB1 mRNA levels
Number of subjects: 150
Study: 29076889

Group type: EXPERIMENTAL
Intervention: TOPS-Family
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: TOPS-TO
Number of subjects: 152

Group type: COMPARATOR
Intervention: IRC
Number of subjects: 152
Study: 26716877

Group type: EXPERIMENTAL
Intervention: Micronized progesterone (400mg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 24434070

Group type: EXPERIMENTAL
Intervention: Group problem-solving skills training (PST)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Both PST and TAU
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: PST
Number of subjects: 433
Study: 22820371

Group type: EXPERIMENTAL
Intervention: Vitamin D (active vitamin D analog compounds); specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D (25‐hydroxy vitamin D); specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized control trials of vitamin D; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 19782391

Group type: EXPERIMENTAL
Intervention: VST-30 silicone elastomer; polymerised for 20 min; exposed to simulated saliva containing C. albicans for 2h.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: VST-50 silicone elastomer; polymerised for 12h; exposed to simulated saliva containing C. albicans for 2h.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: VST-50F silicone elastomer; polymerised for 6h; exposed to simulated saliva containing C. albicans for 2h.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group; simulated saliva and nasal secretion containing C. albicans.
Number of subjects: 48
Study: 17351383

Group type: EXPERIMENTAL
Intervention: Candesartan (8 mg/day)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg/day)
Number of subjects: 71
Study: 16351772

Group type: EXPERIMENTAL
Intervention: Rapidly digestible starch
Number of subjects: 10

Group type: COMPARATOR
Intervention: Slowly digestible starch
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both starches after 14 d adaptation
Number of subjects: 10
Study: 11181473

Group type: EXPERIMENTAL
Intervention: Endothelin A receptor blocker LU 135252 (30 mg/d)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Endothelin A receptor blocker LU 135252 (300 mg/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 9828759

Group type: COMPARATOR
Intervention: 0 g/200 ml phytic acid (totally dephytinized soya milk)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 0.26 g/200 ml phytic acid (natural phytic acid content)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 0.13 g/200 ml phytic acid (half dephytinized soya milk)
Number of subjects: 39
Study: 8006401

Group type: EXPERIMENTAL
Intervention: Terlipressin (2 mg every 6 h)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Vasopressin (0.4 to 0.8 unit per min) plus transdermal nitroglycerin (20 to 80 mg)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Vasopressin plus transdermal nitroglycerin
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 137
Study: 2591221

Group type: EXPERIMENTAL
Intervention: Simultaneous compression-ventilation (SC-V) CPR
Number of subjects: 994

Group type: COMPARATOR
Intervention: Conventional CPR
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 994
Study: 4578134

Group type: EXPERIMENTAL
Intervention: Epipodophyllotoxin VP 16213
Number of subjects: 250
Study: 429083

Group type: EXPERIMENTAL
Intervention: Sustained release theophylline capsule, 250 mg every 12 hours
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (Elixophyllin Elixir, 250 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Isoproterenol inhalation
Number of subjects: 18
Study: 31438797

Group type: EXPERIMENTAL
Intervention: 3D preoperative planning
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional preoperative planning
Number of subjects: 60
Study: 28514458

Group type: EXPERIMENTAL
Intervention: Microneedle-assisted photodynamic therapy with 20-minute ALA incubation
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Microneedle-assisted photodynamic therapy with 10-minute ALA incubation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham roller (control) with 20-minute ALA incubation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham roller (control) with 10-minute ALA incubation
Number of subjects: 33
Study: 26825087

Group type: EXPERIMENTAL
Intervention: Persistent detection of BV-associated bacteria (A. vaginae, BVAB1)
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Endometrial BV-associated bacteria
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Cervical and/or endometrial positivity for BV-associated bacteria
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Ureaplasmas
Number of subjects: 545
Study: 24728104

Group type: EXPERIMENTAL
Intervention: Transperineal ultrasound measurement
Number of subjects: 62

Group type: COMPARATOR
Intervention: Transvaginal ultrasound measurement
Number of subjects: 62